Abstract
Nociceptive primary afferents release glutamate, activating postsynaptic glutamate receptors on spinal cord dorsal horn neurons. Glutamate receptors, both ionotropic and metabotropic, are also expressed on presynaptic terminals, where they regulate neurotransmitter release. During the last two decades, a wide number of studies have characterized the properties of presynaptic glutamatergic receptors, particularly those expressed on primary afferent fibers. This review describes the subunit composition, distribution and function of presynaptic glutamate ionotropic (AMPA, NMDA, kainate) and metabotropic receptors expressed in rodent spinal cord dorsal horn. The role of presynaptic receptors in modulating nociceptive information in experimental models of acute and chronic pain will be also discussed.
Keywords: Spinal cord, pain, glutamate, presynaptic modulation, primary afferent fiber, primary afferent depolarization.
Current Neuropharmacology
Title:Role of Presynaptic Glutamate Receptors in Pain Transmission at the Spinal Cord Level
Volume: 11 Issue: 5
Author(s): Rita Bardoni
Affiliation:
Keywords: Spinal cord, pain, glutamate, presynaptic modulation, primary afferent fiber, primary afferent depolarization.
Abstract: Nociceptive primary afferents release glutamate, activating postsynaptic glutamate receptors on spinal cord dorsal horn neurons. Glutamate receptors, both ionotropic and metabotropic, are also expressed on presynaptic terminals, where they regulate neurotransmitter release. During the last two decades, a wide number of studies have characterized the properties of presynaptic glutamatergic receptors, particularly those expressed on primary afferent fibers. This review describes the subunit composition, distribution and function of presynaptic glutamate ionotropic (AMPA, NMDA, kainate) and metabotropic receptors expressed in rodent spinal cord dorsal horn. The role of presynaptic receptors in modulating nociceptive information in experimental models of acute and chronic pain will be also discussed.
Export Options
About this article
Cite this article as:
Bardoni Rita, Role of Presynaptic Glutamate Receptors in Pain Transmission at the Spinal Cord Level, Current Neuropharmacology 2013; 11 (5) . https://dx.doi.org/10.2174/1570159X11311050002
DOI https://dx.doi.org/10.2174/1570159X11311050002 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Difference Between Accuracy- and Error-Related Brain Activity with Varying Memory Load in Maintenance Phase of Working Memory
Neuroscience and Biomedical Engineering (Discontinued) Recent Approaches Targeting Beta-Amyloid for Therapeutic Intervention of Alzheimer's disease
Recent Patents on CNS Drug Discovery (Discontinued) Adolescence and Borderline Behavior - Between Personality Development and Personality Disorder
Adolescent Psychiatry Herbal Medicine in the Treatment of Epilepsy
Current Drug Targets Carboxylate Binding by Guanidiniocarbonyl Pyrroles: From Self- Assembly to Peptide Receptors
Current Organic Chemistry Diversity-Oriented Synthetic Approaches for Furoindoline: A Review
Current Organic Synthesis Brain Information Sharing During Visual Short-Term Memory Binding Yields a Memory Biomarker for Familial Alzheimer's Disease
Current Alzheimer Research The β-Secretase Enzyme BACE1: A Biochemical Enigma for Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Oxidative stress and myocarditis
Current Pharmaceutical Design Introduction: Strategies, Molecular Targets and Animal Models Useful for Developing Therapies for Alzheimers Disease
Current Medicinal Chemistry - Central Nervous System Agents Radionuclide Imaging in Drug Development
Current Pharmaceutical Design Micronized Palmitoylethanolamide: A Post Hoc Analysis of a Controlled Study in Patients with Low Back Pain – Sciatica
CNS & Neurological Disorders - Drug Targets Modulation of Carbonic Anhydrase 9 (CA9) in Human Brain Cancer
Current Pharmaceutical Design Lipids as Key Players in Alzheimer Disease - Alterations in Metabolism and Genetics
Current Alzheimer Research Current Opinion in the Pharmaceutical Management of Irritable and Inflammatory Bowel Diseases: Role of ATP
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) GLP-1 Agonists and Satiety
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Maternal Fish Oil Supplementation: The Prodrom of Synaptic Protection in Alzheimers Disease
Current Nutrition & Food Science Nano Strategies for Diagnosis and Treatment of Inflammatory Hyperalgesia
Current Nanomaterials Gene Expression Profiling and its Practice in Drug Development
Current Genomics Vaccine Therapy for Hepatitis B Virus Carrier
Current Drug Targets - Infectious Disorders